Here, we present a list of seven putative genes that are modulated by Rsv in breast cancer in the context of cotreatment with Doxo: HSP90AA1, CCND1, CDH1, ESR1, MAPK3, PTPN11, and RPS6KB1. Here, ESR1 is linked to breast carcinoma.